Did You Know? Current preclinical drug testing relies heavily on animal-derived data and animal-derived products which pose multiple issues:
1) Despite efforts to improve the predictability of animal testing, more than 90 percent of promising new compounds fail when they're tested in humans
2) Mouse tissue is in short supply and is expensive, hampering the level of research required to address today’s health epidemics.
3) Current preclinical and clinical drug testing does not include representation of the diverse patient population that the therapies are intended to treat.
As a result:
1) Minority and aging populations are negatively impacted by today’s research and clinical trials.
2) The lack of diversity in research has greatly impeded progress in the fields of
diabetes, obesity, cancer, and wound healing.
Check out Obatala Sciences. This post of theirs says it all!
🔬 Is it time to rethink your research approach?
🤔 Consider this: What if you could switch from animal-derived to human-derived hydrogels for more clinically relevant data and bring new therapeutics to the market faster? Our ObaGel Matrices offer not just one, but TWO solutions to common issues found within the market leading murine-derived hydrogel like inconsistent gelation time, temperature, and matrix stiffness.
💡 Let's talk about advancing your research with the reliability and reproducibility of ObaGel Matrices. Check out this post for real results versus competitors! https://lnkd.in/gHHGpfnc
#Biotech #Hydrogels #ResearchInnovation #HumanDerivedSolutions #MicrophysiologicalSystems #MPS
